Opioid and noradrenergic contributions of tapentadol to the inhibition of locus coeruleus neurons in the streptozotocin rat model of polyneuropathic pain-Reference-Cited by-同舟云学术

Opioid and noradrenergic contributions of tapentadol to the inhibition of locus coeruleus neurons in the streptozotocin rat model of polyneuropathic pain

Published:2018-06 Issue: Volume:135 Page:202-210
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Torres-Sanchez Sonia,Borges Gisela Da Silva,Mico Juan A.,Berrocoso Esther^ORCID

Funder

Grünenthal GmbH

“Ministerio de Economía y Competitividad”

Fondo Europeo de Desarrollo Regional” FEDER

Instituto de Salud Carlos III

Centro de Investigación Biomédica en Red de Salud Mental-CIBERSAM

Consejería de Economía, Innovación, Ciencia y Empleo de la Junta de Andalucía

Fundación Progreso y Salud de la Junta de Andalucía

Brain Behavior Research Foundation

FPI fellowship

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference63 articles.

1. Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the Management of Moderate to Severe Chronic Pain Related to Osteoarthritis of the Knee

2. The function of alpha-2-adrenoceptors in the rat locus coeruleus is preserved in the chronic constriction injury model of neuropathic pain;Alba-Delgado;Psychopharmacology (Berl),2012

3. Comorbid anxiety-like behavior and locus coeruleus impairment in diabetic peripheral neuropathy: a comparative study with the chronic constriction injury model;Alba-Delgado;Prog. Neuro-Psychopharmacol. Biol. Psychiatry,2016

4. Analgesic antidepressants promote the responsiveness of locus coeruleus neurons to noxious stimulation: implications for neuropathic pain;Alba-Delgado;Pain,2012

5. Tolerability, safety, and quality of life with tapentadol prolonged release (PR) compared with oxycodone/naloxone PR in patients with severe chronic low back pain with a neuropathic component: a randomized, controlled, open-label, phase 3b/4 trial;Baron;Pain Pract.,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adrenergic agonists and antagonists enhance opioid receptor activity;The Neurobiology, Physiology, and Psychology of Pain;2022

2. Clinical pharmacology of tramadol and tapentadol, and their therapeutic efficacy in different models of acute and chronic pain in dogs and cats;Journal of Advanced Veterinary and Animal Research;2021

3. Endogenous Opiates and Behavior: 2018;Peptides;2020-10

4. Neuroprotective effect of diosgenin in a mouse model of diabetic peripheral neuropathy involves the Nrf2/HO-1 pathway;BMC Complementary Medicine and Therapies;2020-04-26

5. Tapentadol Suppresses Glutamatergic Transmission and Neuronal Firing in Rat Hippocampal CA3 Pyramidal Neurons;Pharmacology;2019-12-11